Home › Funds › Comprehensive Financial Management LLC › EIKN
Comprehensive Financial Management LLC position in EIKN
EIKON THERAPEUTICS INC · Health Care
Comprehensive Financial Management LLC reported holding 116,276 shares of EIKN (EIKON THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 0.05% of its reported portfolio and ranking #26 among its reported holdings. Comprehensive Financial Management LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Comprehensive Financial Management LLC's EIKN position evolved
Comprehensive Financial Management LLC first disclosed a stake in EIKN in Q1 2026 at 116,276 shares (US$1.2M). The position peaked in Q2 2026 at 116,276 shares, worth US$1.5M. Across 2 filings, Comprehensive Financial Management LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 116,276 shares valued at US$1.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 116.28K | $1.23M | New |
| Q2 2026 | 116.28K | $1.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EIKN and 13F data
EIKN (EIKON THERAPEUTICS INC) is a Health Care company. 88 other funds we track also report a position in EIKN — the largest reported positions include Foresite Capital Management IV, LLC (US$25.4M), Merck & Co., Inc. (US$21.7M), Foresite Capital Management V, LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EIKN
- Foresite Capital Management IV, LLC 1.94M sh · $25.37M · Q2 2026
- Merck & Co., Inc. 1.67M sh · $21.75M · Q2 2026
- Foresite Capital Management V, LLC 1.32M sh · $17.21M · Q2 2026
- EcoR1 Capital, LLC 732.61K sh · $9.56M · Q2 2026
- SOROS CAPITAL MANAGEMENT LLC 484.67K sh · $6.32M · Q2 2026
- StepStone Group LP 395.34K sh · $5.16M · Q2 2026
- General Catalyst Group Management, LLC 305.23K sh · $3.98M · Q2 2026
More on Comprehensive Financial Management LLC
FAQ
How long has Comprehensive Financial Management LLC held EIKN?
Comprehensive Financial Management LLC has disclosed EIKN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Comprehensive Financial Management LLC's current position in EIKN?
As of Q2 2026, Comprehensive Financial Management LLC holds 116.28K shares of EIKN (EIKON THERAPEUTICS INC), valued at $1.52M, representing 0.05% of its reported portfolio and ranking #26.
Has Comprehensive Financial Management LLC been buying or selling EIKN?
In the latest 13F filing (Q2 2026), Comprehensive Financial Management LLC held unchanged its position in EIKN. The position peaked in Q2 2026 at 116.28K shares.
Which other funds hold EIKN?
Other major institutional holders of EIKN include Foresite Capital Management IV, LLC, Merck & Co., Inc., Foresite Capital Management V, LLC, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.